Protein modification by ubiquitin has emerged as an important cellular regulatory mechanism. Recent studies illustrate the surprising ways in which polyubiquitin chains are manipulated in the regulation of NF-κ κB signaling.
Cells respond rapidly to changes in their internal and external environments, often by using post-translational protein modifications to transmit signals from the cell surface or internal sites to the nucleus. These signaling pathways allow cells to respond to growth signals, tolerate stresses or trigger programmed cell death. In general, signaling pathway activation is transient, with feedback mechanisms that reset the regulatory network. Protein phosphorylation, for example, is a well-characterized post-translational mechanism for transmitting transient cellular signals [1] . Phosphate groups, covalently attached to target proteins by substrate-specific protein kinases, can be removed by specific phosphatases, thereby terminating the signaling cascade. Recent studies on the NF-κ κB signaling network indicate that, in addition to transient protein phosphorylation, polyubiquitin chain attachment and removal work as on/off switches at several points along the signal transduction pathways that lead to activation of NF-κ κB family transcription factors.
The carboxyl terminus of the ubiquitin polypeptide is enzymatically appended to lysines on target proteins as well as on other ubiquitin molecules to form polyubiquitin chains. Protein ubiquitination involves the sequential action of ubiquitin-activating enzyme (E1), ubiquitin-conjugating enzyme (E2) and ubiquitin-protein ligase (E3) [2] . E3s bind both E2 and substrate, and facilitate the transfer of ubiquitin molecules from the E2 to the substrate. Ubiquitin is best known as a signal that targets proteins for degradation by the proteasome. In the ubiquitin-proteasome pathway, proteins destined for degradation are usually attached to a polyubiquitin chain in which ubiquitin molecules are linked to one another by amide bonds involving a specific ubiquitin lysine, Lys48 [2] . Proteasomes recognize the Lys48-linked chain, leading to degradation of the substrate and recycling of the ubiquitin molecules. Ubiquitin removal from proteins is catalyzed by a diverse group of enzymes collectively termed deubiquitinating enzymes.
Interplay of Ubiquitination and Phosphorylation in NF-κ κB Regulation As noted, protein phosphorylation and ubiquitination are now both known to participate in the NF-κ κB signaling pathway (Figure 1) [3] . NF-κ κB molecules can concentrate in the nucleus and activate specific genes only when inhibitory controls on NF-κ κB are relieved. This occurs in response to DNA damage, during stimulation by proinflammatory cytokines such as tumor necrosis factor α α (TNFα α) or with an innate immunity response initiated when a ligand interacts with a Tolllike receptor (TLR) [4] . Mature NF-κ κB is normally kept inactive by tight binding to an inhibitory protein called Iκ κB. Activation of NF-κ κB is triggered by site-specific phosphorylation of Iκ κB, which allows Iκ κB to be recognized by a ubiquitin-ligation complex. Polyubiquitinated Iκ κB is degraded by the proteasome, releasing active NF-κ κB . The first hint that A20 function might be linked to ubiquitin was the finding that it has an amino-terminal 'ovarian tumor' (OTU) domain. A20 and several other OTU-related proteins were shown to have deubiquitinating activity [4] . Therefore, a reasonable hypothesis to explain how A20 downregulates NF-κ κB signaling was that A20 removes the Lys63-polyubiquitin signal from proteins such as TRAF6 or RIP.
Wertz et al. [9] have recently reported data that support this idea, but also provide some unexpected twists. They identified RIP as a target for A20 deubiquitinating activity. This activity was traced to the OTU domain, which preferentially removes Lys63-linked ubiquitin chains from RIP. A20 with an active site mutation in the OTU domain failed to turn down NF-κ κB signaling in transfected cells from A20 -/-mice. Surprisingly, purified A20 was also shown to stimulate ubiquitin chain formation in the presence of E1, E2 and ubiquitin. Not only was this E3 activity unanticipated, but A20 lacks any motifs that characterize the majority of the known E3s [2] : the carboxy-terminal half of A20 has seven zinc fingers, and the E3-like activity was traced to the fourth of these (ZnF4). Intriguingly, polyubiquitin chains synthesized by A20 are of the Lys48 variety. This suggested that A20 Current Biology R899 
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The data of Wertz et al. [9] strongly imply that modification of a protein with ubiquitin polymers of different linkage has very different consequences [9] . To date, there is little evidence that chains of different topology have different binding affinities to particular ubiquitin binding domains, although intact TAB2 does prefer Lys63 over Lys48 chains [5] . This preference is lost if the major ubiquitin binding domain in TAB2 is expressed by itself. Perhaps multivalent interactions involving several ubiquitin binding domains in a protein can confer greater chain discrimination. Because proteasomes carry tightly associated E3 ubiquitin-ligase as well as deubiquitinating enzyme subunits [11] , another possibility is that the proteasomal E3(s) preferentially extends Lys48 chains but not Lys63 ones or that the deubiquitinating enzyme(s) preferentially cleaves Lys63 chains. The net effect would be to enhance degradation of Lys48-linked proteins while sparing Lys63-linked ones.
Removal of Lys63-ubiquitin chains from RIP by A20 is insufficient to downregulate TNFα α signaling; signal attenuation also seems to require that A20 synthesize a Lys48-ubiquitin chain on RIP [9] . It is known that proteasomes have a sophisticated 'unfoldase' activity that can pluck individual subunits from a multisubunit complex and degrade them selectively [12] . Lys48-polyubiquitin-modified RIP might be subject to this activity. In this view, Lys63-linked chains facilitate activated complex assembly but Lys48-linked chains trigger proteasome-mediated disassembly (and usually degradation). These ubiquitin chain-dependent mechanisms might be crucial for controlling the duration and strength of signaling in the NF-κ κB pathway and perhaps other signaling pathways.
